Industry Information
-
Ketamine research on the upswing for severe depression
KetamineInterest in the dissociative anesthetic ketamine continues to be strong as a therapy for treatment-resistant depression and similar conditions.2021-11-11 -
Professor Cui Yimin won the first prize of the 16th Chinese Pharmaceutical Association Science and Technology Award in 2021
Professor Cui Yimin of Peking University First Hospital won the honorary title of “The Most Beautiful Scientific and Technical Worker of China Pharmaceutical Association in 2021” at the 2021 China Pharmaceutical Conference held recently.2021-09-23 -
Positive prostate cancer study results for masitinib plus docetaxel
On September 13, Masitinib in combination with docetaxel as a first-line treatment of metastatic castrate refractory prostate cancer (mCRPC) eligible to chemotherapy proved a potential first-line treatment option in the study, AB Science said.2021-09-22 -
The promise of mitochondria-based therapeutics for NASH
Although nonalcoholic steatohepatitis (NASH) is one of the most common types of chronic liver disease in the U.S., it is a disease that is unfamiliar to many Americans. Despite this, its prevalence is increasing, and by some estimates, 27 million Americans will be living with NASH by 2030,while Chinese will reach to 48 million.2021-09-10 -
Novartis’s Kymriah fails in study focused on aggressive B-cell non-Hodgkin lymphoma
Rivals Bristol Myers Squibb and Gilead have succeeded in similar trials.2021-08-26 -
CDC advisory committee recommends additional vaccine dose for immunocompromised
The third booster shot of the COVID-19 vaccine is here, but there are limited applicable people.2021-08-19